The cohosts went back and forth after Al Roker brought up Dreyer’s comment.

Recent research now shows that a sizable number of Americans have been taking GLP-1s off-label. Scientists at New York University and others examined the medical records of Americans across the ...

Children taking GLP-1 medications (such as Victoza, Saxenda, Trulicity, and Ozempic) for weight loss, prediabetes, or type 2 ...

The FDA has warned a major compounding pharmacy that it violated federal law by making copies of blockbuster weight-loss ...

McDonald’s is testing high-protein, smaller-portion menu items as GLP-1 weight-loss drugs influence consumer dining choices.

FDA inspectors found evidence that the compounding pharmacy was making versions of Eli Lilly’s tirzepatide and Novo’s ...

"Eighty-four percent of households with GLP-1 users visit McDonald's. This is an opportunity," McDonald's USA president Skye ...

Researchers say little is known about the risks of GLP-1s for people who don't have an approved medical condition.

Dozens of lawsuits claim the drugs led to vision loss, though evidence is mixed.

A brief report reviews emerging GLP-1 receptor co-agonists that also target GIPR, GCGR, and other receptors, examining their ...

Approximately one in eight U.S. adults is currently taking a GLP-1 drug. Usage is reshaping one of the country's biggest ...

A new study identified more than 1 million people taking weight-loss drugs without any apparent medical reason to do so.